Clinical trial No longer in our active list Interventional Ages 65 and up

Using dexmedetomidine to improve outcomes for elderly ICU patients after surgery

Official title: Impact of Low-dose Dexmedetomidine on Outcomes of Elderly Admitted to ICU After Noncardiac Surgery: a Randomized Controlled Trial

Run by Peking University First Hospital · NCT04204798 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if giving low doses of dexmedetomidine at night can help older patients in the ICU after surgery live longer and feel better over the next year.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment1410 (estimated)
SponsorPeking University First Hospital
Academic / other
Locations1 site (Beijing, Beijing)
Trial IDNCT04204798 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are elderly individuals aged 65 and older who are admitted to the ICU after noncardiac surgery and expected to stay overnight.

Probably not a fit

Patients with pre-existing neurological conditions or severe bradycardia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of low-dose dexmedetomidine on long-term outcomes in elderly patients admitted to the ICU following noncardiac surgery. The study builds on previous findings that showed dexmedetomidine can enhance sleep quality and reduce delirium in ICU patients. Participants will receive either dexmedetomidine or a placebo during nighttime hours, with the aim of assessing its impact on one-year survival rates and overall quality of life. The trial is randomized and controlled, ensuring a robust methodology for evaluating the treatment's effectiveness.

Why it matters

Potential benefit: If successful, this treatment could significantly improve survival rates and quality of life for elderly patients recovering from surgery in the ICU.

How similar studies have gone: Previous studies have shown promising results with dexmedetomidine in similar patient populations, indicating a potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥65 years old;
* Admitted to intensive care unit (ICU) after noncardiac surgery;
* Expected to stay in ICU until the next morning. For those with endotracheal intubation, the expected duration of mechanical ventilation is \<24 hours;
* Provide written informed consents.

Exclusion Criteria:

* Preoperative history of schizophrenia, epilepsy, Parkinsonism, or myasthenia gravis;
* Inability to communicate in the preoperative period (coma, profound dementia, or language barrier);
* Preoperative history of sleep apnea (previous diagnosis; or STOP-Bang score ≥3 with serum bicarbonate ≥ 28 mmol/L);
* Known sick sinus syndrome, severe sinus bradycardia (\<50 beats per min \[bpm\]), or second degree or higher atrioventricular block without pacemaker;
* Hypotension (systolic blood pressure \[SBP\] \<90 mmHg, mean arterial pressure \[MAP\] \<70 mmHg, or a decrease of SBP \>30% of baseline) or in a state of shock (vasopressors are required to maintain MAP ≥65 mmHg and serum lactate \>2 mmol/L);
* Severe hepatic dysfunction (Child-Pugh class C), renal failure (requirement of renal replacement therapy), or expected survival \<24 hours;
* Traumatic brain injury or neurosurgery;
* Presence of delirium before surgery (assessed with Confusion Assessment Method \[CAM\]/CAM-ICU);
* Undergoing treatment of dexmedetomidine or clonidine;
* Other conditions that are considered unsuitable for study participation.

Where it's running

  • Peking University First Hospital
    Beijing, Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.